DISTRIBUTION, FATTY-ACID COMPOSITION AND APOLIPOPROTEIN-A-I IMMUNOREACTIVITY OF HIGH-DENSITY-LIPOPROTEIN SUBFRACTIONS IN MYOCARDIAL-INFARCTION

被引:18
|
作者
MARQUESVIDAL, P
RUIDAVETS, JB
CAMBOU, JP
CAMBIEN, F
CHAP, H
PERRET, B
机构
[1] HOP PURPAN,INSERM,U326,F-31059 TOULOUSE,FRANCE
[2] INSERM,SC7,F-75005 PARIS,FRANCE
关键词
HDL SUBFRACTIONS; FATTY ACIDS; APOLIPOPROTEIN A-I; MYOCARDIAL INFARCTION; CASE-CONTROL STUDY;
D O I
10.1016/0021-9150(94)05394-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The lipoprotein profile, the HDL subfractions and the apolipoprotein (ape) A-I conformation of HDL were determined in 119 patients with myocardial infarction and 119 controls, paired for age. Apo A-I conformation was assessed by its immunoreactivity towards two monoclonal antibodies, 5F6 and 3G10. HDL phospholipid levels and fatty acid composition were also determined. HDL and HDL(3) cholesterol, apo A-I, LpA-I and LpA-I:A-II levels were significantly lower in patients than in controls, whereas the levels of total and LDL-cholesterol and of apo B were not different. Apo A-I immunoreactivity against MAb 5F6 was significantly better in patients than in controls, while the immunoreactivity against 3G10 was similar. Paired stepwise logistic regression showed only apo A-I, HDL(3) cholesterol and 5F6 immunoreactivity to be significantly related to myocardial infarction. After adjustment for HDL cholesterol, lower levels of HDL phospholipids and polyunsaturated fatty acids (PUFA) were found in patients compared with controls. Hence, of all HDL markers, apo A-I and HDL(3) cholesterol appear to be the most informative. Also, lower HDL phospholipid and PUFA content may explain a different apo A-I conformation in patients with myocardial infarction.
引用
收藏
页码:29 / 38
页数:10
相关论文
共 50 条
  • [1] PLASMA HIGH-DENSITY-LIPOPROTEIN SUBFRACTIONS IN SURVIVORS OF MYOCARDIAL-INFARCTION
    WILSON, HM
    PATEL, JC
    SKINNER, ER
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (02) : 330 - 330
  • [2] ACID-PHOSPHATASES BIND TO THE MAIN HIGH-DENSITY-LIPOPROTEIN APOLIPOPROTEIN-A-I
    VIHKO, P
    WAHLBERG, L
    EHNHOLM, C
    LUKKA, M
    VIHKO, R
    FEBS LETTERS, 1986, 202 (02) : 309 - 313
  • [3] APOLIPOPROTEIN-A-I EXPRESSION AND HIGH-DENSITY-LIPOPROTEIN DISTRIBUTION IN TRANSGENIC MICE DURING DEVELOPMENT
    GOLDERNOVOSELSKY, E
    FORTE, TM
    NICHOLS, AV
    RUBIN, EM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (29) : 20787 - 20790
  • [4] TRIIODOTHYRONINE INCREASES RAT APOLIPOPROTEIN-A-I SYNTHESIS AND ALTERS HIGH-DENSITY-LIPOPROTEIN COMPOSITION INVIVO
    APOSTOLOPOULOS, JJ
    MARSHALL, JF
    HOWLETT, GJ
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (01): : 147 - 154
  • [5] APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-A-II ISOFORMS IN PATIENTS WITH HIGH-DENSITY-LIPOPROTEIN DEFICIENCY
    CHOPRA, YM
    KASHYAP, ML
    CLINICAL RESEARCH, 1986, 34 (02): : A289 - A289
  • [6] EFFECTS OF CONJUGATED EQUINE ESTROGEN WITH AND WITHOUT 3 DIFFERENT PROGESTOGENS ON LIPOPROTEINS, HIGH-DENSITY-LIPOPROTEIN SUBFRACTIONS, AND APOLIPOPROTEIN-A-I
    MILLER, VT
    MUESING, RA
    LAROSA, JC
    STOY, DB
    PHILLIPS, EA
    STILLMAN, RJ
    OBSTETRICS AND GYNECOLOGY, 1991, 77 (02): : 235 - 240
  • [7] MONOCLONAL-ANTIBODIES TO HUMAN APOLIPOPROTEIN-A-I - CHARACTERIZATION AND APPLICATION AS STRUCTURAL PROBES FOR APOLIPOPROTEIN-A-I AND HIGH-DENSITY-LIPOPROTEIN
    PETIT, E
    AYRAULTJARRIER, M
    PASTIER, D
    ROBIN, H
    POLONOVSKI, J
    ARAGON, I
    HERVAUD, E
    PAU, B
    BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 919 (03) : 287 - 296
  • [8] HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL - PROGNOSIS AFTER MYOCARDIAL-INFARCTION
    GOLDBOURT, U
    MANDEZWEIG, L
    NEUFELD, HN
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (02) : A42 - A42
  • [9] EFFECT OF FEEDING XENOBIOTICS ON SERUM HIGH-DENSITY-LIPOPROTEIN AND APOLIPOPROTEIN-A-I IN RATS
    ODA, H
    YOSHIDA, A
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1994, 58 (09) : 1646 - 1651
  • [10] HUMAN APOLIPOPROTEIN-A-I LIBERATED FROM HIGH-DENSITY-LIPOPROTEIN WITHOUT DENATURATION
    RYAN, RO
    YOKOYAMA, S
    LIU, H
    CZARNECKA, H
    OIKAWA, K
    KAY, CM
    BIOCHEMISTRY, 1992, 31 (18) : 4509 - 4514